CASTLE BIOSCIENCES, INC. Interest Expense Nonoperating
CASTLE BIOSCIENCES, INC. (CSTL) reported Interest Expense Nonoperating of $193.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. interest expense nonoperating for the quarter ending 2026-06-30 was $193.00K, a 819.05% increase year-over-year.
- CASTLE BIOSCIENCES, INC. interest expense nonoperating for the quarter ending 2026-03-31 was $134.00K, a 688.24% increase year-over-year.
- CASTLE BIOSCIENCES, INC. interest expense nonoperating for the quarter ending 2025-12-31 was $24.00K, a 73.91% decline year-over-year.
- CASTLE BIOSCIENCES, INC. interest expense nonoperating for the quarter ending 2025-09-30 was $24.00K, a 88.06% decline year-over-year.
- CASTLE BIOSCIENCES, INC. interest expense nonoperating for fiscal 2025 was $86.00K, a 85.10% decline from fiscal 2024.
- CASTLE BIOSCIENCES, INC. interest expense nonoperating for fiscal 2024 was $577.00K, a 5145.45% increase from fiscal 2023.
- CASTLE BIOSCIENCES, INC. interest expense nonoperating for fiscal 2023 was $11.00K, a 35.29% decline from fiscal 2022.
- CASTLE BIOSCIENCES, INC. interest expense nonoperating for fiscal 2022 was $17.00K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $193.00K 10-Q · filed 2026-07-30 | $327.00K 10-Q · filed 2026-07-30 | $351.00K derived: sum of 3 quarters · filed 2026-07-30 | $375.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $134.00K 10-Q · filed 2026-05-06 | $158.00K derived: sum of 2 quarters · filed 2026-05-06 | $182.00K derived: sum of 3 quarters · filed 2026-05-06 | $203.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $48.00K derived: sum of 2 quarters · filed 2026-02-26 | $69.00K derived: sum of 3 quarters · filed 2026-07-30 | $86.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $24.00K 10-Q · filed 2025-11-03 | $45.00K derived: sum of 2 quarters · filed 2026-07-30 | $62.00K 10-Q · filed 2025-11-03 | $154.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $21.00K 10-Q · filed 2026-07-30 | $38.00K 10-Q · filed 2026-07-30 | $130.00K derived: sum of 3 quarters · filed 2026-07-30 | $331.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $17.00K 10-Q · filed 2026-05-06 | $109.00K derived: sum of 2 quarters · filed 2026-05-06 | $310.00K derived: sum of 3 quarters · filed 2026-05-06 | $580.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $293.00K derived: sum of 2 quarters · filed 2026-02-26 | $563.00K derived: sum of 3 quarters · filed 2026-02-26 | $577.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $201.00K 10-Q · filed 2025-11-03 | $471.00K derived: sum of 2 quarters · filed 2025-11-03 | $485.00K 10-Q · filed 2025-11-03 | $487.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $270.00K 10-Q · filed 2025-08-04 | $284.00K 10-Q · filed 2025-08-04 | $286.00K derived: sum of 3 quarters · filed 2026-02-26 | $288.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $14.00K 10-Q · filed 2025-05-05 | $16.00K derived: sum of 2 quarters · filed 2026-02-26 | $18.00K derived: sum of 3 quarters · filed 2026-02-26 | $21.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.00K derived: sum of 2 quarters · filed 2026-02-26 | $7.00K derived: sum of 3 quarters · filed 2026-02-26 | $11.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $2.00K 10-Q · filed 2024-11-04 | $5.00K derived: sum of 2 quarters · filed 2024-11-04 | $9.00K 10-Q · filed 2024-11-04 | |
| 2023-06-30 | $3.00K 10-Q · filed 2024-08-05 | $7.00K 10-Q · filed 2024-08-05 | ||
| 2022-12-31 | $17.00K 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |